Patient characteristics by race and diabetes status at MM diagnosis
| Entire cohort, N (%) . | Total 5383 (100%) . | Nondiabetic 4593 (85.3%) . | Diabetic 790 (14.7%) . | P value∗ . |
|---|---|---|---|---|
| Race, n (%) | <.0001 | |||
| Black | 1001 (18.6%) | 754 (16.4%) | 247 (31.3%) | |
| White | 4382 (81.4%) | 3839 (83.6%) | 543 (68.7%) | |
| Gender, n (%) | .0486 | |||
| Female | 2381 (44.2%) | 2057 (44.8%) | 324 (41.0%) | |
| Male | 3002 (55.8%) | 2536 (55.2%) | 466 (59.0%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 326 (6.1%) | 307 (6.7%) | 19 (2.4%) | |
| 45-60 | 1558 (28.9%) | 1373 (29.9%) | 185 (23.4%) | |
| >60 | 3499 (65.0%) | 2913 (63.4%) | 586 (74.2%) | |
| BMI, n (%) | <.0001 | |||
| Underweight | 89 (1.7%) | 85 (1.9%) | 4 (0.5%) | |
| Normal | 1612 (29.9%) | 1460 (31.8%) | 152 (19.2%) | |
| Overweight | 2079 (38.6%) | 1823 (39.7%) | 256 (32.4%) | |
| Obese | 1603 (29.8%) | 1225 (26.7%) | 378 (47.8%) |
| Entire cohort, N (%) . | Total 5383 (100%) . | Nondiabetic 4593 (85.3%) . | Diabetic 790 (14.7%) . | P value∗ . |
|---|---|---|---|---|
| Race, n (%) | <.0001 | |||
| Black | 1001 (18.6%) | 754 (16.4%) | 247 (31.3%) | |
| White | 4382 (81.4%) | 3839 (83.6%) | 543 (68.7%) | |
| Gender, n (%) | .0486 | |||
| Female | 2381 (44.2%) | 2057 (44.8%) | 324 (41.0%) | |
| Male | 3002 (55.8%) | 2536 (55.2%) | 466 (59.0%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 326 (6.1%) | 307 (6.7%) | 19 (2.4%) | |
| 45-60 | 1558 (28.9%) | 1373 (29.9%) | 185 (23.4%) | |
| >60 | 3499 (65.0%) | 2913 (63.4%) | 586 (74.2%) | |
| BMI, n (%) | <.0001 | |||
| Underweight | 89 (1.7%) | 85 (1.9%) | 4 (0.5%) | |
| Normal | 1612 (29.9%) | 1460 (31.8%) | 152 (19.2%) | |
| Overweight | 2079 (38.6%) | 1823 (39.7%) | 256 (32.4%) | |
| Obese | 1603 (29.8%) | 1225 (26.7%) | 378 (47.8%) |
| Black cohort, n (%) . | Total 1001 (100%) . | Nondiabetic 754 (75.3%) . | Diabetic 247 (24.7%) . | P value . |
|---|---|---|---|---|
| Gender, n (%) | .7162 | |||
| Female | 549 (54.8%) | 416 (55.2%) | 133 (53.8%) | |
| Male | 452 (45.2%) | 338 (44.8%) | 114 (46.2%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 81 (8.1%) | 75 (9.9%) | 6 (2.4%) | |
| 45-60 | 351 (35.1%) | 280 (37.1%) | 71 (28.7%) | |
| >60 | 569 (56.8%) | 399 (52.9%) | 170 (68.8%) | |
| BMI, n (%) | .0014 | |||
| Underweight | 13 (1.3%) | 11 (1.5%) | 2 (0.8%) | |
| Normal | 253 (25.3%) | 205 (27.2%) | 48 (19.4%) | |
| Overweight | 374 (37.4%) | 291 (38.6%) | 83 (33.6%) | |
| Obese | 361 (36.1%) | 247 (32.8%) | 114 (46.2%) |
| Black cohort, n (%) . | Total 1001 (100%) . | Nondiabetic 754 (75.3%) . | Diabetic 247 (24.7%) . | P value . |
|---|---|---|---|---|
| Gender, n (%) | .7162 | |||
| Female | 549 (54.8%) | 416 (55.2%) | 133 (53.8%) | |
| Male | 452 (45.2%) | 338 (44.8%) | 114 (46.2%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 81 (8.1%) | 75 (9.9%) | 6 (2.4%) | |
| 45-60 | 351 (35.1%) | 280 (37.1%) | 71 (28.7%) | |
| >60 | 569 (56.8%) | 399 (52.9%) | 170 (68.8%) | |
| BMI, n (%) | .0014 | |||
| Underweight | 13 (1.3%) | 11 (1.5%) | 2 (0.8%) | |
| Normal | 253 (25.3%) | 205 (27.2%) | 48 (19.4%) | |
| Overweight | 374 (37.4%) | 291 (38.6%) | 83 (33.6%) | |
| Obese | 361 (36.1%) | 247 (32.8%) | 114 (46.2%) |
| White cohort, n (%) . | Total 4382 (100%) . | Nondiabetic 3839 (87.6%) . | Diabetic 543 (12.4%) . | P value . |
|---|---|---|---|---|
| Gender, n (%) | .0008 | |||
| Female | 1832 (41.8%) | 1641 (42.7%) | 191 (35.2%) | |
| Male | 2550 (58.2%) | 2198 (57.3%) | 352 (64.8%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 245 (5.6%) | 232 (6.0%) | 13 (2.4%) | |
| 45-60 | 1207 (27.5%) | 1093 (28.5%) | 114 (21.0%) | |
| >60 | 2930 (66.9%) | 2514 (65.5%) | 416 (76.6%) | |
| BMI, n (%) | <.0001 | |||
| Underweight | 76 (1.7%) | 74 (1.9%) | 2 (0.4%) | |
| Normal | 1359 (31.0%) | 1255 (32.7%) | 104 (19.2%) | |
| Overweight | 1705 (38.9%) | 1532 (39.9%) | 173 (31.9%) | |
| Obese | 1242 (28.3%) | 978 (25.5%) | 264 (48.6%) |
| White cohort, n (%) . | Total 4382 (100%) . | Nondiabetic 3839 (87.6%) . | Diabetic 543 (12.4%) . | P value . |
|---|---|---|---|---|
| Gender, n (%) | .0008 | |||
| Female | 1832 (41.8%) | 1641 (42.7%) | 191 (35.2%) | |
| Male | 2550 (58.2%) | 2198 (57.3%) | 352 (64.8%) | |
| Age (y), n (%) | <.0001 | |||
| <45 | 245 (5.6%) | 232 (6.0%) | 13 (2.4%) | |
| 45-60 | 1207 (27.5%) | 1093 (28.5%) | 114 (21.0%) | |
| >60 | 2930 (66.9%) | 2514 (65.5%) | 416 (76.6%) | |
| BMI, n (%) | <.0001 | |||
| Underweight | 76 (1.7%) | 74 (1.9%) | 2 (0.4%) | |
| Normal | 1359 (31.0%) | 1255 (32.7%) | 104 (19.2%) | |
| Overweight | 1705 (38.9%) | 1532 (39.9%) | 173 (31.9%) | |
| Obese | 1242 (28.3%) | 978 (25.5%) | 264 (48.6%) |
χ2P value testing association between patient characteristic and diabetes status within race.